Liquidata Share/ETF/Trust Analysis
Portfolio Holdings Detail for ISIN IE00BF4RFH31
| Stock Name / Fund | iShares MSCI World Small Cap UCITS ETF USD (Acc) |
| Issuer | Blackrock |
| Entity holding fund | iShares III Public Limited Company |
| Entity Type | Umbrella investment company with variable capital and having segregated liability between its funds |
| Entity LEI | 549300PZLRJB7M8H1057 |
| ETF Ticker | WSML(USD) LSE |
| ETF Ticker | WLDS(GBP) LSE |
| ETF Ticker | IUSN(EUR) F |
| ETF Ticker | IUSN.DE(EUR) CXE |
| ETF Ticker | WLDS.LS(GBP) CXE |
| ETF Ticker | WSML.LS(USD) CXE |
| ETF Ticker | WSML.L(GBP) LSE |
| ETF Ticker | WLDS.L(GBP) LSE |
Holdings detail for MLTX
| Stock Name | MoonLake Immunotherapeutics |
| Ticker | MLTX(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
Show aggregate MLTX holdings
News associated with MLTX
- Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) PT at $74.43
- Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average […] - 2025-09-22 02:42:53
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives Consensus Rating of “Moderate Buy” from Brokerages
- Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have been given an average recommendation of “Moderate Buy” by the nine research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and seven have assigned a buy recommendation to the company. The average 1 […] - 2025-08-25 02:15:07
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Raised to “Hold” at Redburn Atlantic
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was upgraded by research analysts at Redburn Atlantic to a “hold” rating in a report issued on Monday,Zacks.com reports. Several other analysts also recently commented on the stock. Royal Bank Of Canada reaffirmed an “outperform” rating and set a $67.00 price objective on shares of MoonLake Immunotherapeutics in […] - 2025-07-30 02:20:44
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Trading Up 2.7% – Still a Buy?
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) shares traded up 2.7% during trading on Wednesday . The stock traded as high as $48.02 and last traded at $47.86. 425,225 shares were traded during mid-day trading, an increase of 11% from the average session volume of 384,204 shares. The stock had previously closed at $46.61. Wall […] - 2025-07-03 04:28:52
- The Math Shows ESML Can Go To $48
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-18 08:03:21
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Earns “Outperform” Rating from Royal Bank of Canada
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “outperform” rating reiterated by equities researchers at Royal Bank of Canada in a research report issued to clients and investors on Tuesday,Benzinga reports. They presently have a $67.00 price objective on the stock. Royal Bank of Canada’s target price points to a potential upside of […] - 2025-06-05 02:29:04
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 15:06:39
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 14:07:37
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 12:48:38
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 10:35:23
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 08:48:55
- Universal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 20,141 MoonLake Immunotherapeutics (NASDAQ:MLTX)
- Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in the 4th quarter, HoldingsChannel.com reports. The firm acquired 20,141 shares of the company’s stock, valued at approximately $1,091,000. Several other hedge funds also recently added to or reduced their stakes in the stock. Deutsche Bank AG […] - 2025-06-04 05:24:49
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-04 03:47:05
- Stocks Finish Higher on Chip Stock Strength and Healthy US Labor Market
- The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.58%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.79%. June E-mini S&P futures (ESM25 ) are up +0.58%, and June E-mini Nasdaq futures... - 2025-06-03 23:49:46
- Stocks Climb as Chip Makers Rally and US Job Openings Increase
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 18:26:24
- Stocks Climb as Chip Makers Rally and US Job Openings Increase
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 14:47:08
- MoonLake Immunotherapeutics Breaks Above 200-Day Moving Average - Bullish for MLTX
- In trading on Tuesday, shares of MoonLake Immunotherapeutics (Symbol: MLTX) crossed above their 200 day moving average of $45.66, changing hands as high as $49.48 per share. MoonLake Immunotherapeutics shares are currently trading up about 18.7% on the day. The chart below sho - 2025-06-03 14:16:02
- Stocks Climb as Chip Makers Rally and US Job Openings Increase
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.19%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.58%. June E-mini S&P futures (ESM25 ) are up +0.34%, and June E-mini Nasdaq futures... - 2025-06-03 14:05:31
- Stocks See Support as Bond Yields Slide
- The S&P 500 Index ($SPX ) (SPY ) today is up +0.03%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.06%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.10%. June E-mini S&P futures (ESM25 ) are up +0.07%, and June E-mini Nasdaq futures... - 2025-06-03 12:50:06
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Shares Purchased by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.
- MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 13.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 15,456 shares of the company’s stock after purchasing an additional 1,866 shares during the period. […] - 2025-05-27 04:47:04
- Nuveen Asset Management LLC Boosts Stock Holdings in MoonLake Immunotherapeutics (NASDAQ:MLTX)
- Nuveen Asset Management LLC increased its stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 2.5% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 595,581 shares of the company’s stock after purchasing an additional 14,792 shares during the quarter. Nuveen Asset Management LLC […] - 2025-05-22 05:58:59
- Wolfe Research Upgrades MoonLake Immunotherapeutics (NASDAQ:MLTX) to Outperform
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) was upgraded by analysts at Wolfe Research from a “peer perform” rating to an “outperform” rating in a report released on Monday, MarketBeat Ratings reports. The firm presently has a $61.00 price target on the stock. Wolfe Research’s price objective would indicate a potential upside of 51.44% from […] - 2025-05-21 02:42:44
- Ameriprise Financial Inc. Boosts Stake in MoonLake Immunotherapeutics (NASDAQ:MLTX)
- Ameriprise Financial Inc. boosted its position in shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) by 28.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 204,373 shares of the company’s stock after purchasing an additional 45,113 shares during the period. Ameriprise […] - 2025-05-19 04:30:54
- Dimensional Fund Advisors LP Takes Position in MoonLake Immunotherapeutics (NASDAQ:MLTX)
- Dimensional Fund Advisors LP acquired a new stake in MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in the fourth quarter, Holdings Channel.com reports. The firm acquired 64,384 shares of the company’s stock, valued at approximately $3,485,000. A number of other institutional investors and hedge funds have also made changes to their positions in MLTX. PNC Financial […] - 2025-05-14 04:32:47
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.50 Consensus Price Target from Analysts
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are presently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. […] - 2025-04-25 02:52:47
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Sets New 12-Month Low – What’s Next?
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) hit a new 52-week low during trading on Monday . The stock traded as low as $34.13 and last traded at $35.04, with a volume of 339603 shares. The stock had previously closed at $37.21. Analyst Ratings Changes MLTX has been the topic of a number of recent […] - 2025-04-08 04:50:55
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Receives $80.50 Average PT from Analysts
- MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) has been assigned an average rating of “Buy” from the eight brokerages that are covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating on the company. […] - 2025-03-31 02:46:59
- MoonLake Immunotherapeutics (NASDAQ:MLTX) Now Covered by Royal Bank of Canada
- Royal Bank of Canada assumed coverage on shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) in a research report released on Tuesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $67.00 price target on the stock. Several other analysts have also recently commented on the company. HC Wainwright reissued a “buy” rating and […] - 2025-03-19 05:12:49
- ESGV's Underlying Holdings Imply 20% Gain Potential
- Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-10 09:44:02
- Brokerages Set MoonLake Immunotherapeutics (NASDAQ:MLTX) PT at $83.20
- Shares of MoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report) have earned a consensus recommendation of “Buy” from the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has assigned a strong buy recommendation to […] - 2025-03-06 04:45:40
iShares MSCI World Small Cap UCITS ETF USD (Acc) MLTX holdings
| Date | Number of MLTX Shares Held | Base Market Value of MLTX Shares | Local Market Value of MLTX Shares | Change in MLTX Shares Held | Change in MLTX Base Value | Current Price per MLTX Share Held | Previous Price per MLTX Share Held |
|---|
| 2025-10-15 (Wednesday) | 16,881 | USD 166,953 | USD 166,953 | | | | |
| 2025-10-10 (Friday) | 16,764 | USD 171,999 | USD 171,999 | | | | |
| 2025-10-08 (Wednesday) | 16,764 | USD 152,552 | USD 152,552 | | | | |
| 2025-10-07 (Tuesday) | 16,764 | USD 155,570 | USD 155,570 | 78 | USD 11,069 | USD 9.28 | USD 8.66001 |
| 2025-10-06 (Monday) | 16,686 | USD 144,501 | USD 144,501 | 0 | USD 3,838 | USD 8.66001 | USD 8.43 |
| 2025-10-03 (Friday) | 16,686 | USD 140,663 | USD 140,663 | 0 | USD 16,185 | USD 8.43 | USD 7.46003 |
| 2025-10-02 (Thursday) | 16,686 | USD 124,478 | USD 124,478 | 0 | USD 6,675 | USD 7.46003 | USD 7.05999 |
| 2025-10-01 (Wednesday) | 16,686 | USD 117,803 | USD 117,803 | 0 | USD -1,836 | USD 7.05999 | USD 7.17002 |
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdingsShare Trades of MLTX by Blackrock for IE00BF4RFH31
Show aggregate share trades of MLTX| Date | Action | Quantity | Market High | Market Low | Likely Trade Price | Likely Trade Value (Profit/Loss) | Average Price previous trades |
|---|
| 2025-10-07 | BUY | 78 | | | 9.280* | | 44.04 |
| 2025-09-08 | SELL | -140 | | | 61.120* | | 44.97 Profit of 6,296 on sale |
| 2025-08-15 | BUY | 70 | | | 54.390* | | 44.92 |
| 2025-08-07 | BUY | 204 | | | 51.890* | | 44.82 |
| 2025-07-29 | BUY | 68 | | | 52.350* | | 44.58 |
| 2025-07-14 | BUY | 140 | | | 50.860* | | 44.22 |
| 2025-06-30 | BUY | 140 | | | 47.200* | | 44.06 |
| 2025-06-25 | BUY | 210 | | | 47.370* | | 43.99 |
| 2025-06-20 | SELL | -36 | | | 43.500* | | 43.98 Profit of 1,583 on sale |
| 2025-06-12 | SELL | -280 | | | 44.020* | | 44.00 Profit of 12,319 on sale |
| 2025-06-02 | BUY | 108 | | | 41.160* | | 43.85 |
| 2025-05-28 | BUY | 72 | | | 38.170* | | 43.96 |
| 2025-05-14 | BUY | 36 | | | 36.990* | | 44.38 |
| 2025-05-13 | BUY | 72 | | | 38.540* | | 44.42 |
| 2025-05-07 | BUY | 108 | | | 37.600* | | 44.60 |
| 2025-04-28 | BUY | 35 | | | 39.150* | | 44.82 |
| 2025-04-16 | BUY | 468 | | | 36.970* | | 45.25 |
| 2025-04-14 | BUY | 72 | | | 35.750* | | 45.42 |
| 2025-04-08 | SELL | -72 | | | 32.835* | | 45.85 Profit of 3,301 on sale |
| 2025-04-04 | SELL | -72 | | | 37.210* | | 46.04 Profit of 3,315 on sale |
| 2025-03-28 | BUY | 360 | | | 39.860* | | 46.36 |
| 2025-03-12 | SELL | -72 | | | 39.310* | | 47.34 Profit of 3,408 on sale |
| 2025-03-04 | SELL | -72 | | | 40.300* | | 47.89 Profit of 3,448 on sale |
| 2025-02-26 | SELL | -144 | | | 42.370* | | 48.23 Profit of 6,945 on sale |
| 2025-02-13 | BUY | 36 | | | 43.600* | | 49.02 |
| 2025-02-12 | BUY | 144 | | | 44.270* | | 49.09 |
| 2025-01-27 | BUY | 36 | | | 44.890* | | 49.95 |
| 2025-01-23 | BUY | 36 | | | 46.880* | | 50.09 |
| 2024-12-09 | BUY | 1,296 | | | 52.750* | | 50.02 |
| 2024-12-04 | BUY | 70 | | | 53.060* | | 49.78 |
| 2024-12-03 | BUY | 105 | | | 51.300* | | 49.75 |
| 2024-11-19 | BUY | 216 | | | 49.330* | | 48.51 |
| 2024-11-18 | BUY | 72 | | | 48.540* | | 48.51 |
| 2024-11-12 | BUY | 140 | | | 51.890* | | 48.40 |
| 2024-11-11 | BUY | 35 | | | 53.890* | | 48.03 |
| 2024-11-11 | BUY | 35 | | | 53.890* | | 48.03 |
| 2024-11-07 | BUY | 175 | | | 50.670* | | 47.51 |
| 2024-11-07 | BUY | 175 | | | 50.670* | | 47.51 |
| 2024-10-23 | BUY | 70 | | | 46.590* | | 48.34 |
| 2024-10-23 | BUY | 70 | | | 46.590* | | 48.34 |
Market high and low price is on the date. * (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection
The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close
Shorting History of MLTX
| Date | Shorted Volume | Short Exempt Volume | Total Shares Traded | % Shorted |
|---|
| 2025-09-19 | 188,436 | 0 | 302,507 | 62.3% |
| 2025-09-18 | 179,800 | 0 | 338,697 | 53.1% |
| 2025-09-17 | 207,082 | 0 | 355,102 | 58.3% |
| 2025-09-16 | 400,608 | 0 | 662,803 | 60.4% |
| 2025-09-15 | 266,921 | 0 | 337,273 | 79.1% |
| 2025-09-12 | 149,846 | 18 | 400,142 | 37.4% |
| 2025-09-11 | 180,042 | 0 | 360,799 | 49.9% |
| 2025-09-10 | 262,341 | 4,844 | 400,784 | 65.5% |
| 2025-09-09 | 123,516 | 0 | 305,154 | 40.5% |
| 2025-09-08 | 175,744 | 0 | 327,197 | 53.7% |
| 2025-09-05 | 394,083 | 0 | 897,447 | 43.9% |
| 2025-09-04 | 201,886 | 0 | 324,754 | 62.2% |
| 2025-09-03 | 469,114 | 0 | 616,481 | 76.1% |
| 2025-09-02 | 146,535 | 0 | 273,930 | 53.5% |
| 2025-08-29 | 134,910 | 0 | 228,162 | 59.1% |
| 2025-08-28 | 113,582 | 0 | 194,815 | 58.3% |
| 2025-08-27 | 64,927 | 0 | 100,136 | 64.8% |
| 2025-08-26 | 139,408 | 0 | 245,320 | 56.8% |
| 2025-08-25 | 108,764 | 0 | 229,723 | 47.3% |
| 2025-08-22 | 50,960 | 7 | 100,307 | 50.8% |
| 2025-08-21 | 77,715 | 0 | 237,211 | 32.8% |
| 2025-08-20 | 113,744 | 0 | 147,261 | 77.2% |
| 2025-08-19 | 57,404 | 0 | 105,853 | 54.2% |
| 2025-08-18 | 95,185 | 0 | 181,060 | 52.6% |
| 2025-08-15 | 78,221 | 0 | 144,504 | 54.1% |
| 2025-08-14 | 63,545 | 0 | 111,234 | 57.1% |
| 2025-08-13 | 76,412 | 0 | 197,989 | 38.6% |
| 2025-08-12 | 44,456 | 0 | 114,221 | 38.9% |
| 2025-08-11 | 76,161 | 0 | 108,361 | 70.3% |
| 2025-08-08 | 108,671 | 33,674 | 146,885 | 74.0% |
| 2025-08-07 | 74,314 | 2,100 | 136,888 | 54.3% |
| 2025-08-06 | 126,874 | 0 | 189,350 | 67.0% |
| 2025-08-05 | 109,154 | 506 | 211,512 | 51.6% |
| 2025-08-04 | 159,692 | 0 | 222,687 | 71.7% |
| 2025-08-01 | 260,138 | 0 | 327,016 | 79.5% |
| 2025-07-31 | 207,750 | 2,123 | 296,733 | 70.0% |
| 2025-07-30 | 226,238 | 1,759 | 562,460 | 40.2% |
| 2025-07-29 | 62,123 | 0 | 187,985 | 33.0% |
| 2025-07-28 | 123,865 | 0 | 201,175 | 61.6% |
| 2025-07-25 | 85,314 | 0 | 170,364 | 50.1% |
| 2025-07-24 | 97,312 | 14 | 171,667 | 56.7% |
| 2025-07-23 | 163,330 | 0 | 301,588 | 54.2% |
| 2025-07-22 | 91,516 | 0 | 178,782 | 51.2% |
| 2025-07-21 | 52,151 | 0 | 75,742 | 68.9% |
| 2025-07-18 | 116,354 | 0 | 214,689 | 54.2% |
The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.
Back to Listing
Disclaimer
All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.